"Efficacy of Galcanezumab in Patients Who Failed to Respond to Preventives Previously: Results from EVOLVE-1, EVOLVE-2 and REGAIN Studies (S20.004)." Neurology
90.15 Supplement
(2018):
S20.004.
Web. 25 Jan. 2021.
Advertisement
The most widely read and highly cited peer-reviewed neurology journal
